Home > Cashflow Statement > LACTOSE (INDIA)

LACTOSE (INDIA)
Cashflow Statement

LACTOSE (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for LACTOSE (INDIA)
Please provide your vote to see the results

LACTOSE (INDIA) Last 5 Year Cashflow Statement History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit Before Tax₹6.92 Cr₹9.66 Cr₹1.46 Cr₹3.17 Cr₹-3.27 Cr
Adjustment ₹10 Cr₹9.94 Cr₹11 Cr₹9.60 Cr₹9.85 Cr
Changes In working Capital ₹-16 Cr₹-10 Cr₹-4.13 Cr₹-4.36 Cr₹-4.44 Cr
Cash Flow after changes in Working Capital ₹0.84 Cr₹9.52 Cr₹7.94 Cr₹8.40 Cr₹2.13 Cr
Cash Flow from Operating Activities ₹-0.29 Cr₹8.75 Cr₹7.89 Cr₹8.47 Cr₹2.17 Cr
Cash Flow from Investing Activities ₹-16 Cr₹-2.08 Cr₹-0.92 Cr₹-0.56 Cr₹-6.18 Cr
Cash Flow from Financing Activities ₹19 Cr₹-5.72 Cr₹-8.32 Cr₹-8.14 Cr₹4.52 Cr
Net Cash Inflow / Outflow ₹2.95 Cr₹0.95 Cr₹-1.34 Cr₹-0.24 Cr₹0.51 Cr
Opening Cash & Cash Equivalents ₹1.53 Cr₹0.58 Cr₹1.92 Cr₹2.16 Cr₹1.65 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations -----
Closing Cash & Cash Equivalent ₹4.48 Cr₹1.53 Cr₹0.58 Cr₹1.92 Cr₹2.16 Cr

Compare Cashflow Statement of peers of LACTOSE (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LACTOSE (INDIA) ₹130.7 Cr 1.8% -9.5% 3.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹456,989.0 Cr 1.7% 6.4% 12.1% Stock Analytics
DIVIS LABORATORIES ₹179,471.0 Cr 3% 2.8% 0.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹161,290.0 Cr 2.3% 9.1% 44.6% Stock Analytics
CIPLA ₹117,820.0 Cr 0.3% 6.1% -3.7% Stock Analytics
DR REDDYS LABORATORIES ₹114,730.0 Cr -0.1% 8.9% 1.9% Stock Analytics


LACTOSE (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
LACTOSE (INDIA)

1.8%

-9.5%

3.4%

SENSEX

0.9%

4.2%

-6%


You may also like the below Video Courses